go back

Nebraska rates for HCPCS Q2053

Brexucabtagene autoleucel, up to 200 million autologous anti-CD19 CAR positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $524,807 · 10th–90th $478,630–$977,2370%20%40%10th90th$524,807Professionalmedian $489,779 · 10th–90th $489,779–$741,3100%50%90th$489,779$500.0K$1.0M$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$489,778.82 / $724,435.96 / $977,237.22
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $741,310.24
BCBS
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$398,107.17 / $524,807.46 / $537,031.80
BCBS
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$575,439.94 / $588,843.66 / $602,559.59
Cigna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$457,088.19 / $489,778.82 / $588,843.66
Medica
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$446,683.59 / $691,830.97 / $891,250.94
Medica
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$512,861.38 / $1,000,000.00 / $1,000,000.00
Midlands
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$512,861.38 / $512,861.38 / $630,957.34
Midlands
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$512,861.38 / $588,843.66 / $724,435.96
United
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$446,683.59 / $489,778.82 / $977,237.22
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$467,735.14 / $489,778.82 / $588,843.66